A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial
Related Posts
Morad TT, Keykhaei M, Terraciano DA, Srivastava PK, Yang EH, Stein-Merlob AF. Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology[...]
Anukam DC, Nianogo RA, Arah OA, Rao J, Fowke JH, Hashibe M, Zhang ZF. Sleep duration and prostate cancer-specific mortality in the Southern Community Cohort[...]
Chen KL, Pollack CE, Qureshi I, Zimmerman FJ, Kennedy-Hendricks A, Robinson L, Linton SL, Ge Y, Eisenberg MD, Leifheit KM. Tenant Right-to-Counsel and Emergency Department[...]